ATC code - J07CA09
SpainDiphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b
-
Form: suspension for injection
Active substance Dosage diphtheria toxoid 20 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg haemophilus influenzae type b capsular polysaccharide prp 12 µg ATC code: J07C, J07CA, J07CA09
Manufacturer: Sanofi Winthrop Industrie
-
Form: suspension for injection, in pre-filled syringe
Active substance Dosage tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg h. influenzae type b polysaccharide tetanus toxoid conjugate 12 µg diphtheria toxoid 20 UI ATC code: J07C, J07CA, J07CA09
Manufacturer: Sanofi Winthrop Industrie
-
Form: suspension for injection
Active substance Dosage diphtheria toxoid 20 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg haemophilus influenzae type b capsular polysaccharide prp 12 µg ATC code: J07C, J07CA, J07CA09
Manufacturer: Sanofi Winthrop Industrie
-
Form: powder and solvent for injectable suspension
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI h. influenzae type b polysaccharide tetanus toxoid conjugate 0,02 mg haemophilus influenzae type b 0,01 mg bordetella pertussis toxoid 0,025 mg bordetella pertussis filamentous hemagglutinin 0,025 mg bordetella pertussis 69 kd outer membrane protein 0,01 mg poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 0,01 mg ATC code: J07C, J07CA, J07CA09
Manufacturer: Glaxosmithkline Biologicals
-
Form: powder and solvent for injectable suspension
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI h. influenzae type b polysaccharide tetanus toxoid conjugate 20 µg haemophilus influenzae type b 10 µg bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg bordetella pertussis 69 kd outer membrane protein 10 µg poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg ATC code: J07C, J07CA, J07CA09
Manufacturer: Glaxosmithkline Biologicals
-
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid Mayor o igual a 20 UI tetanus toxoid Mayor o igual a 40 UI bordetella pertussis toxoid 20 µg bordetella pertussis filamentous hemagglutinin 20 µg bordetella pertussis pertactin 3 µg pertussis fimbriae agglutinogen toxoid 5 µg inactivated poliovirus type 1 mahoney produced in vero cells 29 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 7 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 26 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg conjugate haemophilus influenzae prp-neisseria meningitidis ompc 3 µg ATC code: J07C, J07CA, J07CA09
Manufacturer: Mcm Vaccine B.V.